Gephyrin antibody (N-Term)

Catalog No. ABIN630781

This Rabbit Polyclonal antibody specifically detects Gephyrin in WB. It exhibits reactivity toward Human, Mouse and Rat.

Quick Overview for Gephyrin antibody (N-Term) (ABIN630781)

Target: Gephyrin (GPHN)

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Gephyrin antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-Gephyrin Antibody

Binding Specificity: N-Term

Specificity: Gephyrin antibody was raised against the N terminal of GPHN

Purification: Affinity purified

Immunogen: Gephyrin antibody was raised using the N terminal of GPHN corresponding to a region with amino acids HDELEDLPSPPPPLSPPPTTSPHKQTEDKGVQCEEEEEEKKDSGVASTED

Application Details

Application Notes: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

Gephyrin Blocking Peptide, catalog no. 33R-3708, is also available for use as a blocking control in assays to test for specificity of this Gephyrin antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of GPHN antibody in PBS

Concentration: Lot specific

Buffer: PBS

Handling Advice: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Storage: 4 °C/-20 °C

Storage Comment: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Target Details for Gephyrin

Target: Gephyrin (GPHN)

Alternative Name: Gephyrin

Background: GPHN is a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described, however, the full-length nature of all transcript variants is not currently known.

Molecular Weight: 80 kDa (MW of target protein)

Pathways: Synaptic Membrane, Skeletal Muscle Fiber Development